|
SEC23A expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.33459998608032E-09 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.18840004503795E-09 |
| Normal-vs-Stage2 |
6.579200E-03 |
| Normal-vs-Stage3 |
4.007600E-04 |
| Normal-vs-Stage4 |
3.631200E-04 |
| Stage1-vs-Stage2 |
2.139800E-01 |
| Stage1-vs-Stage3 |
8.798200E-01 |
| Stage1-vs-Stage4 |
8.803600E-01 |
| Stage2-vs-Stage3 |
3.450600E-01 |
| Stage2-vs-Stage4 |
3.411000E-01 |
| Stage3-vs-Stage4 |
9.980200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.86390014533799E-10 |
| Normal-vs-AfricanAmerican |
3.021800E-01 |
| Normal-vs-Asian |
9.120100E-02 |
| Caucasian-vs-AfricanAmerican |
5.66149999999821E-05 |
| Caucasian-vs-Asian |
8.028800E-01 |
| AfricanAmerican-vs-Asian |
4.926000E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.139699994963E-08 |
| Normal-vs-Female |
9.27800000161128E-08 |
| Male-vs-Female |
8.945400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.066450E-02 |
| Normal-vs-Age(41-60Yrs) |
1.68979999992658E-08 |
| Normal-vs-Age(61-80Yrs) |
3.5515999996516E-07 |
| Normal-vs-Age(81-100Yrs) |
1.809380E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.636200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.395200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.463200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.806200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.676800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.202000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.366370E-04 |
| Normal-vs-Grade 2 |
6.55980003649859E-09 |
| Normal-vs-Grade 3 |
3.15809999995587E-06 |
| Normal-vs-Grade 4 |
1.103330E-03 |
| Grade 1-vs-Grade 2 |
5.790000E-01 |
| Grade 1-vs-Grade 3 |
4.486600E-01 |
| Grade 1-vs-Grade 4 |
5.593000E-01 |
| Grade 2-vs-Grade 3 |
4.306400E-01 |
| Grade 2-vs-Grade 4 |
7.754000E-01 |
| Grade 3-vs-Grade 4 |
8.104800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.68109970388741E-11 |
| Normal-vs-ccB subtype |
1.91179999999846E-05 |
| ccA subtype-vs-ccB subtype |
5.896200E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.45989999878316E-08 |
| Normal-vs-N1 |
1.253430E-01 |
| N0-vs-N1 |
5.009200E-01 |
|
|
